Cerebrovascular disorders in patients with type 2 diabetes mellitus and resistant hypertension

BACKGROUND: Diabetes mellitus (DM) and hypertension are risk factors for cerebral stroke, which are exacerbated by the combination of these diseases. Identifying the factors involved in the development of subclinical brain damage could change the therapeutic strategy for protecting the brain.

AIM: to study severity of MRI- sings of brain damage and to identify factors associated with their development in patients with type 2 diabetes and RHTN.

MATERIALS AND METHODS: 46 patients with type 2 DM and RHTN were included in a single-center observational uncontrolled study. Patients underwent brain MRI (1.5 Tesla) with calculation of Evans’s index (EI), clinical and lab examinations (HbA1c, glucose, insulin, C-peptide, leptin, resistin, TNF- α, hsCRP, blood aldosterone, insulin-like growth factor-1 (IGF-1)), measurement of the office and ambulatory blood pressure (BP), assessment of peripheral and cerebral vasoreactivity (test with hyperventilation and breath holding).

RESULTS: The most frequent MR brain changes were white matter lesions (WML) in periventricular region (PVR) (89%), focal WML (52%) and expansion both of the ventricles (45%) and subarachnoid spaces (65%). Multiple direct correlations were revealed between parameters of carbohydrate metabolism with the degree of WML in PVR and the density of the MR-signal in the basal nucleus (BN), as well as with EI. Adipokines had a direct relationship with the size of the chiasmatic cistern and IE (for resistin), as well as with the density of the MR signal from the BN and IE (for leptin), that was also directly related to the IGF-1 level. The aldosterone level positively correlated with the size of III ventricle. An increase in TNF-α and hsCRP was accompanied by an increase in the density of the MR-signal in the PVR. Impairment of cerebrovascular reactivity is associated with an increase in the density of the MR-signal in PVR and with indirect signs of cerebral atrophy (increase in EI, the size of cisterns and lateral ventricles). Impairment of peripheral vasoreactivity had direct relationship with EI and the expansion of the III ventricle. There were no direct correlations between the severity of MR-sings of brain damage and BP levels.

CONCLUSION: The combination of type 2 DM with RHTN is characterized by a high frequency of WML and liquorodynamics disturbances, which related with metabolic, neurohormonal and hemodynamic factors in the absence of a direct relationship with the degree of BP increase

1. Dedov II, Shestakova MV, Vikulova OK, et al. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes mellitus. 2019;22(2S):4-61. (In Russ.). doi: https://doi.org/10.14341/DM12208

2. Dedov II, Kalashnikova MF, Belousov DY, et al. Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM). Diabetes mellitus. 2017;20(6):403-419. (In Russ.). doi: https://doi.org/10.14341/DM9278

3. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222. doi: https://doi.org/10.1016/S0140-6736(10)60484-9

4. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327-338. doi: https://doi.org/10.2147/DMSO.S51325

5. Zhang Y, Jiang X, Bo J, et al. Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients. Journal of Hypertension. 2018;36(1):93-100. doi: https://doi.org/10.1097/HJH.0000000000001528

6. Ryumshina NI, Baev A, Falkovskaya AYu, et al. MRI with paramagnetic contrast enhancement of the arterial vascular wall in follow-up control of therapeutic effect in resistant arterial hypertension treated with radiofrequency ablation of sympathetic plexus of the renal arteries. Medical Visualization. 2019;(1):56-64. (In Russ.). doi: https://doi.org/10.24835/1607-0763-2019-1-56-64

7. Usov WYu, Yaroshevsky SP, Tlyuniaeva AM, et al. Quantitative processing of T2-weighted cerebral MRI concomitant with thin-slice cortex measurements in patients with severe carotid atherosclerosis for prognosis of cerebral complications after invasive cardiovascular interventions. Diagnostic radiology and radiotherapy. 2018;4:48-56. (In Russ.). doi: https://doi.org/10.22328/2079-5343-2018-4-48-56

8. Debette S, Schilling S, Duperron MG, et al. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurology. 2019;76(1):81-94. doi: https://doi.org/10.1001/jamaneurol.2018.3122

9. Grebennikov DA, Sitnikov EV, Ananyev VK. Differential diagnosis of brain atrophy and hydrocephaly. Public health of the Far East. 2017;72(2):51-54. (In Russ.).

10. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology. 2018;34(5):575-584. doi: https://doi.org/10.1016/j.cjca.2017.12.005

11. Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957-980. doi: https://doi.org/10.1016/S0140-6736(21)01330-1

12. Mohammad А, Abujbara М, Alshraideh J, et al. The Prevalence of Resistant Hypertension Among Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology, and Genetics. Journal of Endocrinology and Metabolism. 2017;7(5):153-158. doi: https://doi.org/10.14740/jem448e

13. Schneider ALC, Selvin E, Sharrett AR, et al. Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS). Diabetes Care. 2017;40:1514-1521. doi: https://doi.org/10.2337/dc17-1185.

14. Ogama N, Sakurai T, Kawashima S, et al. Postprandial hyperglycemia is associated with white matter hyperintensity and brain atrophy in older patients with type 2 diabetes mellitus. Front. Aging Neurosci. 2018;10:273. doi: https://doi.org/10.3389/fnagi.2018.00273

15. Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;(65):252-256. doi: https://doi.org/10.1161/HYPERTENSIONAHA.114.03617

16. Climie RE, Moran C, Callisaya M, et al. Abdominal Obesity and Brain Atrophy in Type 2 Diabetes Mellitus. PLoS One. 2015;10(11):e0142589. doi: https://doi.org/10.1371/journal.pone.0142589

17. Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660-667. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.07802

18. Cuadrado-Godia E, Dwivedi P, Sharma S, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. Journal of Stroke. 2018;20(3):302. doi: https://doi.org/10.5853/jos.2017.02922

19. Ni Y, Teng T, Li R, et al. TNF-α alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS One. 2017;12(2):e0170346. doi: https://doi.org/10.1371/journal.pone.0170346

20. Zyubanova IV, Mordovin VF, Pekarskiy SE, et al. Possible mechanisms of renal denervation long-term cardiac effects. Arterial Hypertension. 2019;25(4):423-432. (In Russ.). doi: https://doi.org/10.18705/1607-419X-2019-25-4-423-432